staurosporine has been researched along with HPV Infection in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bosset, M; Decrion-Barthod, AZ; Launay, S; Marchini, A; Mougin, C; Nicolier, M; Plissonnier, ML; Prétet, JL; Rommelaere, J | 1 |
Bernard, B; Fest, T; Mougin, C; Prétet, JL | 1 |
2 other study(ies) available for staurosporine and HPV Infection
Article | Year |
---|---|
Sodium butyrate with UCN-01 has marked antitumour activity against cervical cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Butyrates; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Female; HeLa Cells; Human papillomavirus 16; Human papillomavirus 18; Humans; Mice; Mice, Nude; Papillomavirus Infections; Staurosporine; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2010 |
Staurosporine-induced apoptosis of HPV positive and negative human cervical cancer cells from different points in the cell cycle.
Topics: Apoptosis; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Nucleus; Drug Administration Schedule; Female; Flow Cytometry; G1 Phase; G2 Phase; HeLa Cells; Human papillomavirus 18; Humans; In Situ Nick-End Labeling; Papillomavirus Infections; Staurosporine; Uterine Cervical Neoplasms | 2001 |